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a  b  s  t  r  a  c  t
Aim:  In previous  reports  both  microcirculatory  alterations  and  impaired  vascular  reactivity  have  been
described  in post  cardiac  arrest  patients  treated  with  mild  therapeutic  hypothermia.  As  of now  it  is
unknown  whether  these  alterations  are  related  to the  temperature  management  or to  the  cardiac  arrest
itself.  Aim of  the present  study  was  to  investigate  the potential  difference  in  microcirculatory  alter-
ations  and vascular  reactivity  in  comatose  patients  after  out  of  hospital  cardiac  arrest  treated  with  target
temperature  management  of  33 ◦C  (TTM33)  in comparison  to patients  treated  with  36 ◦C  (TTM36).
Methods:  Our study  was  designed  as  a predeﬁned  substudy  of  the  open  label  randomized  controlled  TTM
trial  in 2 Dutch  mixed  ICU’s.  Sublingual  microvascular  ﬂow  index  (MFI)  was  assessed  by Side  Stream
Darkﬁeld  imaging  and  vascular  reactivity  at the  thenar  region  of the  hand  by near  infrared  spectroscopy.
Variables,  including  systemic  hemodynamics  were  recorded  at start  study  (T1),  after  12 h  (T2)  and  after
24 h  (T3).
Results:  22 patients  were  included,  13 in TTM33  and  9  in  TTM36.  At T1  MFI  between  groups  did  not  differ
signiﬁcantly  (1.08  [0.4–1.9]  versus  1.67  [0.7–2.4]  respectively,  p  = 0.59).  The  difference  between  groups
remained  insigniﬁcant  over  time.  At T1  tissue  oxygenation  (StO2) was signiﬁcantly  lower  in  TTM36  in
comparison  to TTM33:  (44.6  ±  15.8  versus  58.9  ±  13.5,  p = 0.03).  Over  time  this  difference  between  groups
disappeared.  However,  vascular  reactivity,  expressed  as the  descending  and  ascending  slope  of StO2 after
a standardized  ischemic  occlusion  test  was  similar  between  groups.
Conclusions:  In  this  relatively  small  sample  size  study  microcirculatory  blood  ﬂow  and  vascular  reactivity
did  not  differ  nor  change  between  TTM33  and  TTM36.
©  2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
After cardiopulmonary resuscitation (CPR), following an out-of-
ospital cardiac arrest (OHCA) hemodynamic failure is common,
ue to a combination of heart failure and ischemia reperfusion
I/R) injury. Comatose post-cardiac arrest patients are treated in the
ntensive care unit (ICU) with mild therapeutic hypothermia (33◦),
 A Spanish translated version of the abstract of this article appears as Appendix
n  the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2014.09.025.
 Clinicaltrials.gov nr. NCT01850485.
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nowadays referred to as target temperature management (TTM)
for an assumed neuroprotective effect.6 Experimental studies
and previous clinical trials suggest an improvement in mortal-
ity and neurological function during hypothermia after cardiac
arrest, However in the recently published TTM trial that com-
pared a regimen of 33 ◦C vs 36 ◦C no difference in outcome
was observed.18 Irrespective of the level of hypothermia well-
known clinical signs of shock may  be blunted during TTM. Blood
pressure, pulse rate, urine production and skin temperature are
all inﬂuenced by TTM itself. Moreover, therapeutic strategies
such as deep sedation, necessary to counteract the physiological
response of the human body to hypothermia may  obscure the
clinical picture. Interpretation of variables, including cardiac out-
put, venous saturation as well as lactate is complicated during
TTM.
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In a recent retrospective observational study in the Medi-
al Center Leeuwarden in 62 patients after cardiac arrest, we
bserved a rise in cardiac index (CI) and ScvO2 during steady state
ypothermia (TTM33) in conjunction with a signiﬁcant increase of
actate levels.2,5 Although lactate is a well-known marker of tis-
ue hypoperfusion, increasing concentrations may  also result from
ther reasons, such as metabolic changes. This raised the question
hether TTM itself indeed attenuates I/R-injury-induced changes
n tissue perfusion.
In the last decade in vivo microscopy of tissue perfusion with
ide Stream Darkﬁeld (SDF) imaging has become available at the
edside of critically ill patients.3 Recent studies indicate that alter-
tions in sublingual microcirculatory blood ﬂow not only can
e observed and quantiﬁed, but are also associated with patient
utcome.1 During and after cardiac arrest and CPR microcirculatory
ow abnormalities indicated by Microvascular Flow Index (MFI)
ave been observed and appeared to predict outcome.3
Changes in muscle tissue oxygenation (StO2) after an ischemic
ncident using near-infrared spectroscopy (NIRS) were found in
atients with sepsis and in particular in septic shock. Also NIRS
ay  be a useful technique to monitor microcirculatory changes in
atients after cardiac arrest.4
In this study we tested the hypothesis that, in patients after
HCA, treatment with TTM33 is associated with an increase in
icrocirculatory ﬂow abnormalities, in comparison to patients
reated with TTM36 as measured by SDF (MFI) and tissue oxygen-
tion (NIRS).
. Patients and methods
.1. Design and settings
This research study was a sub-study of the target temperature
anagement (TTM) trial.18 In this TTM study patients were ran-
omized after OHCA for a 24-h management with temperature
ontrol at 33 ◦C versus 36 ◦C. Our substudy was carried out in two
utch large teaching hospitals, the Medical Center Leeuwarden and
he Onze Lieve Vrouwe Gasthuis. Both Intensive Care Units are
2-bed, mixed medical, surgical and cardiothoracic surgical units
nd Intensivist directed. This study was carried out between March
012 and January 2013.
.2. Ethical approval
The research protocol and consent procedures were approved
y the ethics committee, RTPO Leeuwarden. Informed consent was
btained from the legal representative of the patient. Informed con-
ent was also obtained from the patient, as soon the patient was
ble to judge the situation. The protocol was recorded on clinical-
rials.gov nr. NCT01850485.
.3. Inclusion and exclusion criteria
All patients above 18 years of age with return of sponta-
eous circulation (ROSC), but remaining comatose after OHCA were
creened. Exclusion criteria were absence of informed consent,
ecent maxillofacial surgery, and participation in other clinical tri-
ls.
.4. Randomization and blinding
The patients were randomized in a 1:1 ratio via a web-based
pplication using a center-stratiﬁed, block-permuted randomiza-
ion scheme with varying block sizes. Concerning blinding; given
he procedure caregivers could not be blinded for TTM. Collection
f data was purely based on objective already stored computeration 86 (2015) 14–18 15
data. Analysis of data, including interpretation of SDF images was
blinded.
2.5. Sample size
Based on earlier research13 we anticipated a mean MFI  at base-
line of 2.5 with a standard deviation of 0.4. We  calculated a sample
size of 2 × 11 patients to detect an absolute difference in MFI of 0.5
in a two-sided test with an  ˛ of 0.05 and an 80% power.
2.6. Protocol
By protocol (TTM main protocol), after randomization, all
patients, both TTM33 and TTM36 experienced guided circula-
tory resuscitation in order to optimize systemic hemodynamic
variables in accordance with the basic principles of early
goal-directed therapy.7 Systemic hemodynamic assessment was
achieved through continuous invasive monitoring of arterial blood
pressure and right heart catheterization with continuous cardiac
output and central venous oxygen saturation (Vigilance®, Edwards
Lifesciences, Saint-Prex, Switzerland). Until a pulmonary artery
catheter was  in place, the use of ﬂuids and vasoactive agents was at
the discretion of the attending physician, whose goal was to main-
tain a minimal mean arterial pressure (MAP) of 75 mm Hg. After
calibration, treatment of circulatory failure was  performed using
the following strict hierarchical order: (1) establishment of ﬂuid-
responsiveness by repeated infusions of at least 250 ml crystalloids,
colloids or blood products, until the increase in left ventricular
stroke volume is less than 10%, or until the pulmonary artery
wedge pressure exceeds 18 mm Hg. (2) Treatment of inadequate
oxygen delivery, deﬁned as a central venous oxygen saturation
<70%, with dopamine administered at up to 10 g/kg/min and
additional enoximone in the event of an inadequate response to
dopamine. (3) Reversal of hypotension with norepinephrine in case
of MAP  < 75 mm Hg despite the afore mentioned steps. The use of
hydrocortisone up to a maximum of 100 mg  iv 3 times per day was
permitted for shock reversal in case of vasopressor dependency;
in general the red blood cell transfusion trigger was a haemat-
ocrit <25%. Patients in both groups were sedated, endotracheally
intubated and mechanically ventilated.
2.7. Measurements of tissue perfusion
In vivo microscopy of sublingual microcirculatory blood ﬂow
was performed with a SDF camera (Microscan®, Microvision Med-
ical, Amsterdam, the Netherlands), and subsequent quantiﬁcation
was done in accordance with the guidelines from a round table
conference.12 Microvascular ﬂow was semi-quantitatively graded
from 0 (absent), 1 (intermittent), 2 (sluggish) to 3 (normal). The
overall MFI  was  an average of 12 scores (4 quadrants times 3 win-
dows of observation).8 The measurements were done by a trained
research nurse or intensivist.
Tissue saturation (StO2) and vascular reactivity4 was assessed
with near infrared spectroscopy (NIRS) (Invos 5100C) at the thenar
region of the hand, in combination with a standardized occlusion
maneuver of the forearm.11 This test was  performed by inﬂating
a pneumatic cuff around the upper arm to 50 mm Hg above the
systolic pressure for 3 min  to follow the evolution of StO2. NIRS
is a technique that utilizes near-infrared light to measure chro-
mophores in tissues. The analysis of changes in StO2 during a brief
episode of forearm ischemia enables quantiﬁcation of microvas-
cular dysfunction. This vasoreactivity test evaluates a different
aspect of microvascular function than ﬂow; it evaluates microvas-
cular oxygen uptake reserve more than actual microvascular
perfusion.

















































36 patients after OHCA
22 patients included
randomization
Excluded: 14 no informed consent
[0.3–2], p = 0.01).
The SOFA score as indicator of organ failure was signiﬁcantly
higher after 24 h in the TTM33 group (11 [10–13] versus 9 [7–13],
p = 0.04).
Table 1
Characteristics at start study.
Variables TTM33 TTM36 p
(n = 13) (n = 9)
Gender: male, n (%) 12 (92.3%) 6 (66.7%) 0.13
Age,  years 68.9 (±9.3) 64.3 (±12.4) 0.42
Temperature in ◦C (at
admission)
35.2 (±0.8) 35.5 (±0.95) 0.55
CPR  time to ROSC in
minutes
26.3  (±10.7) 22 (±15.2) 0.48
OHCA rhythm VF(n) 12 6 0.13
Non-shockable (n) 1 3
APACHE IV 134.4 (±13.6) 94.6 (±24.2) 0.39
Mean arterial pressure,
mm  Hg
84.9 (±14.0) 79.2 (±18.5) 0.45
Heart rate, beats per
minute
78.3 (±14.7) 79.4 (±13.6) 0.85
Cardiac index, l/m2 2.38 (±0.84) 2.07 (±0.63) 0.356 M. Koopmans et al. / Re
.8. Data collection
At baseline, the following data were recorded; general char-
cteristics, severity of illness with Acute Physiology and Chronic
ealth Evaluation (APACHE) IV9 and Sequential Organ Failure
ssessment (SOFA),10 Glasgow Coma Score (GCS), use of vasopres-
ors and mechanical ventilation. Systemic hemodynamics, SDF and
IRS measurements were recorded at start study (T1), after 12 h
T2) and 24 h (T3). Length of stay in de ICU and survival status of
ach participant was conﬁrmed. The moment of start study (T1) is
s soon as the patient reached the targeted temperature.
The primary endpoint of this study was sublingual microcircu-
atory blood ﬂow as deﬁned by microcirculatory ﬂow index (MFI)
t T1, T2 and T3. Secondary endpoints were StO2, descending and
scending slope, ﬂuid balance after the ﬁrst 24 h, use of inotropes
nd vasopressor dose, cardiac index, lactate, and SvO2.
.9. Statistical analyses
In general, all data were tested for normal distribution with the
olmogorov Smirnov test. Histograms and normal-quantile plots
ere visually inspected to verify the normality of distribution of
ontinuous variables.
First the demographic characteristics were analyzed. Variables
ere expressed as mean and standard deviation or medians and
nterquartile ranges according their distribution.
Secondly, the microcirculation as the primary outcome was
ompared. To test differences in microcirculatory blood ﬂow using
DF, expressed as MFI, we used the Mann–Whitney U test. To
nalyze differences in time courses StO2 Anova for repeated mea-
urements followed by paired t-test or non-parametric was  used as
ecessary. A Bonferroni correction was used to correct for multiple
omparison.
Finally the hemodynamic and biological data were compared.
ariables were expressed as mean and standard deviation or
edians and interquartile ranges according to their distribution.
ifferences between group means were tested by the student t-test
r Mann–Whitney U test.
A p value of <0.05 was considered statistically signiﬁcant.
The Statistical Package for Social Sciences (SPSS 19 for Windows,
hicago, IL, USA) is used for statistical analyses.
. Results
All adult patients between March 2012 and January 2013, admit-
ed to the ICU after an OHCA, were screened for this study. Out of
6 eligible patients 22 were included. Informed consent could not
e obtained in 14 cases (see Fig. 1). All 22 patients were included
ithin 4 h after ROSC. By central computerized randomization 13
atients were allocated to TTM33 and 9 patients at TTM36 for 24 h.
ne patient died after 5 h in the TTM33 group, the other 21 patients
ompleted the study protocol. Eighty-one percent of the patients
ere male, with a mean age of 67 (±9.9) with a mean time to ROSC
f 24.8 ± 11.4 min. Baseline characteristics are provided in Table 1.
.1. Microcirculatory variables
MFI  was altered in both groups at T1 (Table 2). The MFI  in TTM33
as lower in comparison to TTM36, but this was not statistically
igniﬁcantly different (1.08 [0.4–1.9] versus 1.67 [0.7–2.4], p = 0.55).
n both groups the MFI  returned to normal during the 24 follow
p period. There was no statistical difference between the two
roups on T2, (2.2 [1.6–2.5] versus 1.8 [1.2–2.7], p = 0.59) and T3,
2.6 [1.5–2.9] versus 2.8 [1.7–3], p = 0.55) on our primary outcome.
StO2 as measured by NIRS at T1 (start study) was signiﬁ-
antly lower in the TTM36 as compared to TTM33 (59.8 ± 13.7 and13 patients TTM3 3 9 patients  TTM3 6
Fig. 1. Flowchart. 36 patients after OHCA
44.6 ± 15.8, p = 0.03) (Table 2). This difference between groups dis-
appeared after 12 and 24 h. We  found no difference in StO2 in both
groups over time. The descending and ascending slopes of StO2 after
a standardized occlusion maneuver of the forearm were not differ-
ent between the two temperature groups, nor over time (Table 2).
3.2. Hemodynamic and biological data
As shown in Table 3 patients in the TTM33 group had a signif-
icantly lower heart rate (64.5 ± 13.8 versus 81.6 ± 19.1, p = 0.04), a
higher lactate level (2.78 (±1.1) versus 1.71 (±0.5), p = 0.03) and
hemoglobin level (8.88 (±0.6) versus 8.21 (±0.4), p = 0.02) in com-
parison to the TTM36 group at start study. The TTM33 group was
ventilated with signiﬁcant more PEEP (12 (±2.4) versus 10 (±1.4),
p = 0.04) and higher FiO2 (0.48 (±0.16) versus 0.37 (±0.7), p = 0.03).
We also observed a signiﬁcant difference in ﬂuid balance, with the
TTM33 group receiving more ﬂuids (3.3 L (±1.2) versus 1.8 L (±0.9),
p = 0.02).
Glucose levels were not signiﬁcantly different, but the insulin
used to reach this levels is signiﬁcant higher in the TTM33 group at
start study (2.6 [0–8] versus 0.8 [0–2], p = 0.02) and the total insulin
use is signiﬁcant higher in the TTM33 group (2.0 [1.5–3] versus 1.5Lactate, mmol/l 5.55 (±2.2) 4.83 (±3.6) 0.45
GCS, Glasgow Coma Scale; APACHE, Acute Physiology and Chronic Health Evalua-
tion; SOFA, Sepsis-related Organ Failure Assessment. All data are presented as mean
(±SD), median (IQR) or as numbers (%).
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Table  2
Microcirculatory variables.
Start study (T1) p After 12 h (T2) p After 24 h (T3) p
TTM33 TTM36 TTM33 TTM36 TTM33 TTM36
MFI  1.1 [0.4–1.9] 1.7 [0.7–2.4] 0.59 2.2 [1.6–2.5] 1.8 [1.2–2.7] 0.59 2.6 [1.5–2.9] 2.8 [1.7–3] 0.55
StO2 58.9 (±13.5) 44.6 (±15.8) 0.03 65.0 (±12.2) 49.0 (±12.6) 0.07 61.7 (±10.2) 52 (±9.88) 0.09
Dec  −0.15(0.08) −0.14(0.05) 0.70 −0.15(0.07) −0.16(0.08) 0.85 −0.14(0.04) −0.13(0.08) 0.38































AFI  = Microvascular Flow Index; StO2 = tissue oxygenation; Dec = descending slope 
nalyzed with the Mann–Whitney U test.
. Discussion
The hypothesis tested was that in patients after OHCA, treat-
ent with TTM33 would be associated with an increase in
icrocirculatory ﬂow abnormalities, in comparison to patients
reated with TTM36. However, in our study there was no difference
n MFI  between TTM33 and TTM36, our primary outcome. Indeed,
here was a difference in tissue saturation at T1, with a signiﬁcant
igher StO2 in TTM33. But this was not accompanied by a differ-
nce in vascular reactivity, as expressed by the StO2 recovery slope.
his was associated with a lower heart rate, higher lactate levels,
igher use of insulin, higher hemoglobin, higher PEEP and FiO2, a
ore positive ﬂuidbalance and a higher SOFA score in comparison
o TTM36.
In accordance with previous reports, in our study early post
esuscitation phase was characterized by signiﬁcant abnormalities
n microvascular ﬂow.14 This returns to normal within the next
4 h. Donadello et al. observed in TTM33 a MFI  of 2.1 (±0.5) in the
rst 12 h after ICU admission and an MFI  of 2.8 (0.2) after 24–48 h.
n our study the TTM36 group seemed to have a slightly higher MFI
n comparison to the TTM33 group, but this was not statistically
igniﬁcant. Moreover, in both groups MFI  normalized over time.
ypothermia does not seem to have a relation with microvascular
lterations.
Van Genderen et al.15 investigated the microcirculatory per-
usion and alterations and concluded that the abnormalities in
ublingual microcirculation were independent of systemic hemo-
ynamics and suggested that the observed alterations were
robably due to hypothermia-induced vasoconstriction. However,
he fact that in our data microcirculatory alterations were not
able 3
emodynamic, therapeutic and biological data at the start of the study, after 12 and 24 h
Start study (T1) p After 12 h
TTM33 TTM36 TTM33 
Mean arterial pressure,
mm  Hg
79.1 (12.7) 70.4 (12.1) 0.13 73 (8.86) 
Heart  rate, beats per
minute
64.5 (13.8) 81.6 (19.1) 0.04 60.2 (9.7)
Cardiac Index, l/m2 1.9 (0.73) 2.1 (0.64) 0.42 2.1 (0.74
Lactate, mmol/l 2.78 (1.05) 1.71 (0.48) 0.03 3.48 (2.2
pH  7.32 (0.08) 7.38 (0.11) 0.24 7.3 (0.08
PaO2, kPa 14.4 (4.6) 17.1 (4.1) 0.08 13.4 (2.7)
SvO2, % 69.4 (10.27) 61.2 (13.56) 0.20 71.8 (8.9)
Glucose, mmol/l 10.6 (3.69) 8.7 (2.72) 0.22 7.1 (2.9)
Actrapid, ml/h 2.6 (0–6) 0.83 (0–2) 0.02 2.5 (1–8
Platelets, g/l 242.3 (60.3) 204.7 (38.6) 0.12
Hemoglobin, mmol/l 8.88 (0.63) 8.21 (0.44) 0.02 8.9 (0.85
Noradrenaline,
mcg/kg/min
0.087  (0.081) 0.090 (0.089) 0.89 0.093 (0
Dopamine, mcg/kg/min 0.00 (0.00–4.89) 0.00 (0.0–1.9) 0.55 0.00 (0.0
Peep,  cm H2O 11.96 (2.4) 9.75 (1.39) 0.04 10.8 (2.49
FiO2,% 0.48 (0.16) 0.37 (0.7) 0.03 0.40 (0.1
Fluidbalance, L 
SOFA,  points 
ll data expressed as mean (SD), median (IQR) and analyzed with the T-test or Mann–Wh; Asc = ascending slope in %/s. All data expressed as mean (SD) or median (IQR) and
different between two target-temperatures, suggests alternative
causes, although a targeted temperature of 36 ◦C may  be considered
hypothermia to some extent
In septic patients it is known that presence and persistence of
alterations in tissue oxygenation (StO2) in the ﬁrst 24 h are asso-
ciated with worse outcome.4 Donadello et al.14 found no changes
in StO2 over time during hypothermia. In our study we observed a
signiﬁcant difference at time point 1 (start study) between groups;
StO2 was signiﬁcantly lower in TTM36 as compared to TTM33
(59.8 (±13.7) and 44.6 (±15.8), p = 0.03). But this difference disap-
peared after 12 and 24 h. A higher StO2 in the TTM33 group may  be
explained by a lower oxygen consumption in response to hypother-
mia. Alternatively, a higher StO2 may  be present during shunting.
Since the catchment area of the StO2 probe incorporates both cap-
illary and venous blood, this cannot be ruled out, and is in line with
the observed higher lactate levels. However, the data on the micro-
circulation, especially the MFI, which was  found to be low in these
patients, did not support shunting as an explanation for the increase
in StO2 and lactate. An alternative explanation for the higher lactate
levels in TTM33 could be metabolic: the liver might not be able to
metabolize sufﬁcient lactate under conditions of hypothermia. It is
of note, however that the difference in StO2 between groups dis-
appeared over time despite maintenance of the target temperature
level during this observation period. This may be in line with the
concept of oxygen deﬁcit and oxygen debt. An initial greater mis-
balance between oxygen delivery and consumption in the TTM36
maybe reﬂected by a prolonged recovery period of the StO2. Sim-
ilar observations have been done in patients with reduced oxygen
delivery capacity such as heart failure19 An alternative explana-
tion for this transient disappearance of a signiﬁcant difference of
.
 (T2) p After 24 h (T3) p
TTM36 TTM33 TTM36
66.5 (7.3) 0.16 70.6 (13.2) 93.6 (17.3) 0.17
 79.6 (12.5) 0.00 71.9 (6.9) 78.3 (9.7) 0.01
) 2.1 (0.74) 0.08 2.3 (0.49) 3.0 (0.67) 0.02
) 1.6 (0.84) 0.01 2.73 (1.51) 2.17 (1.73) 0.46
7) 7.34 (0.014) 0.14 7.34 (0.07) 7.34 (0.05) 0.83
 11.9 (2.0) 0.33 14.0 (3.27) 14.0 (3.15) 0.94
 75.8 (4.95) 0.40 74.2 (7.8) 73.4 (6.2) 0.72
 5.8 (1.1) 0.43 6.18 (1.81) 6.97 (1.85) 0.20
) 1.69 (0–4.5) 0.33 2.58 (0.5–12) 1.62 (0–4) 0.46
) 8.2 (0.66) 0.10 8.68 (1.25) 8.13 (0.80) 0.18
.013) 0.097 (0.011) 0.94 0.12 (0.12) 0.07 (0.09) 0.29
0–1.9) 0.05 (0.0–0.32) 0.53 0.50 (0.92) 0.22 (0.63) 0.36
) 10.1 (1.46) 0.53 10.9 (1.57) 9.5 (1.41) 0.06
1) 0.33 (0.4) 0.11 0.37 (0.6) 0.33 (0.3) 0.07
3.33 (1.18) 1.79 (0.92) 0.02
11 (10–13) 9 (7–13) 0.04
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tO2 between groups over time may  be a difference in the speed of
eduction of oxygen consumption between groups.
Microvascular reactivity as expressed in the descending and
scending slope of the StO2 was unpredictable and gave a large
nter-individual variability. There was no signiﬁcant difference in
eactivity between TTM33 and TTM36. This variability was  also
escribed by Donadello et al.14 in a group of hypothermic patients.
Limitations of the study were related to the small sample size.
n our sample size calculation, we anticipated a MFI  of 2.5 with a
D of 0.4, but this is not in agreement with the actual observations.
ith regard to the reliability, the observed differences between
he groups are well beyond the described coefﬁcients of variation
f both SDF and NIRS.16,17 Secondly, there was a large inter-
ndividual variability in the microvascular reactivity. Therefore, a
mall difference between groups may  have been undetected in this
tudy.
. Conclusion
Although this is a small sample size study, our data suggest that
fter OHCA, the microvascular ﬂow index is altered, independent
f TTM33 or TTM36. Since there was found no statistical differ-
nce between groups, we reject our hypothesis that a difference
n temperature management under TTM is associated with alter-
tions in microvascular blood ﬂow. Since tissue oxygenation at the
tart of the study appears to be higher in the TTM33 group, without
 rise in shunt fraction, reduction of oxygen consumption, or atten-
ation of oxygen debt seems to be the most logical explanation for
his outcome. This suggests that in clinical practice elevation of lac-
ate levels during hypothermia may  not only reﬂect impaired organ
erfusion and other causes should be considered.
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